Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis

Summary

Rational of study : 3,4-diaminopyridine is suspected to improved the fatigue associated in patient's multiple sclerosis. In order to confirm this hypothesis, a randomized, controlled versus placebo, double blinded study is performed.

Timeline

Start

2005-02

Primary completion

2008-06

Completion

2008-06

Drugs

Indications